New publication: TEFM variants impair mitochondrial transcription causing childhood-onset neurological disease

Lochmüller Lab Members Published as Authors in Nature Communications Study

We are excited to share that the study “TEFM variants impair mitochondrial transcription causing childhood-onset neurological disease”, containing contributions from several lab members, was published in the journal Nature Communications on February 23, 2023. Postdoc members Dr. Kiran Polavarapu and Dr. Emily O’Connor, along with Dr. Hanns Lochmüller, are all authors on the paper.

This international, multi-center study establishes TEFM as a  candidatemitochondrial disease gene. Recessive or biallelic TEFM mutations were identified in seven patients from five unrelated families with a wide range of infantile or childhood-onset neurological and neuromuscular symptoms. A combination of clinical phenotyping and muscle pathology along with in silico protein analysis, and mitochondrial function investigations helped in establishing the causal effect of TEFM in these patients. Findings from patients were further supported by zebrafish studies, including movement and neuromuscular analysis1.

These data suggest the consideration of TEFM in the genetic diagnostic workup of patients that present with neonatal or childhood onset mitochondrial encephalomyopathy with  fatigable muscle weakness, epilepsy and variable degree of intellectual disability, and some of these patients with neuromuscular junction defect can benefit from early therapeutic intervention.

Read the Full Publication

The article is open access, and available to read here: https://pubmed.ncbi.nlm.nih.gov/36823193/.

Reference

  1. Van Haute, L., O'Connor, E., Díaz-Maldonado, H., Munro, B., Polavarapu, K., Hock, D. H., Arunachal, G., Athanasiou-Fragkouli, A., Bardhan, M., Barth, M., Bonneau, D., Brunetti-Pierri, N., Cappuccio, G., Caruana, N. J., Dominik, N., Goel, H., Helman, G., Houlden, H., Lenaers, G., Mention, K., … Horvath, R. (2023). TEFM variants impair mitochondrial transcription causing childhood-onset neurological disease. Nature communications, 14(1), 1009. https://doi.org/10.1038/s41467-023-36277-7. PMID: 36823193

 

Neuromuscular junction and animal models

Read next...

We are hiring a new clinical research coordinator!

Lochmüller Research Group Hiring Clinical Trial Coordinator

Due to recent funding success and expansion of our clinical trials team we have a need for a highly motivated Research Coordinator that will assist...
First participant screened in global CMS natural history study

The Ottawa Neuromuscular Centre screens first participant in the world for a multinational congenital myasthenic syndrome natural history study

The neuromuscular centre at The Ottawa Hospital is excited to announce that we are the first site globally to screen a participant for the multinational...
Copy of Lochmuller Lab - PhD opportunity (LLab)

Lochmüller Lab seeking PhD student

The Lochmüller Research Group are seeking a highly motivated PhD student to join our team at the Childrens Hospital of Eastern Ontario Research Institute (CHEO...
New Publication - Leading global expert in DMD and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for biphosphonate therapy in glucocorticoid-treated patients with Duchenne Muscular Dystrophy in Neurology, with Dr. Hanns Lochmüller as a co-author.

New Publication: Bisphosphonates in Glucocorticoid-Treated Patients with Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence

Leading global expert in Duchenne Muscular Dystrophy (DMD) and bone health Dr. Leanne Ward publishes systematic review and grading of evidence for bisphosphonate therapy in...
text reding new clinical trial opportunities

New Clinical Trial Opportunities for Children and Adults in Ottawa

Our clinical research team is excited to share five new clinical trials activated across both pediatric and adult sites in Ottawa, CHEO and TOH. We...
Dr. Andreas Roos receiving award on WMS 2023 stage, with text reading Congratulaions Dr. Andreas Roos, WMS President's Prize for Emerging Myologist of the Year 2023.

Dr. Andreas Roos wins Emerging Myologist of the Year Prize at WMS 2023

We are excited to congratulate Dr. Andreas Roos on winning the World Muscle Society’s (WMS) President’s Prize for Emerging Myologist of the Year!   This award...